The Scientific Director of the GCRM comments on the new drug Kisspeptin and developments in IVF
A new discovery of the hormone Kisspeptin has been widely quoted in the press in articles such as this one on the BBC, as being a major breakthrough in IVF.
I asked Professor Richard Fleming to share some insights on how it might benefit patients and whether the claims made for Kisspeptin are valid. He says:
He goes on to say
As with any new treatment, further tests and trial are required but new developments often result in greater understanding of the body's processes. Prof Fleming says: